Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap.
about
The asthma-COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease?Pharmacological strategies to reduce exacerbation risk in COPD: a narrative reviewAsthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.Soluble receptor for advanced glycation end-products and progression of airway diseaseConcomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease.A novel biomarker in the diagnosis of parapneumonic effusion: neutrophil gelatinase-associated lipocalinBiological clustering supports both "Dutch" and "British" hypotheses of asthma and chronic obstructive pulmonary disease.Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controlsAnalysis of mitochondrial DNA alteration in new phenotype ACOS.Is a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD?Advanced glycation endproducts and their receptor in different body compartments in COPDInflammatory biomarkers in asthma-COPD overlap syndrome.Characterization of sputum biomarkers for asthma-COPD overlap syndromeRelationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease SeverityAsthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review.Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary diseaseAsthma research in China: a five-year review.Biomarker discovery in asthma and COPD by proteomic approaches.The asthma COPD overlap syndrome (ACOS).Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.Phenotype of asthma-chronic obstructive pulmonary disease overlap syndrome.Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma?Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokersThe use of cellular and molecular biomarkers to manage COPD exacerbations.The IRONy of Iron-overload and Iron-deficiency in Chronic Obstructive Pulmonary Disease.Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma-COPD overlap syndrome phenotype.Association of asthma-chronic obstructive pulmonary disease overlap syndrome with coronary artery disease, cardiac dysrhythmia and heart failure: a population-based retrospective cohort study.A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype.Osteoporosis in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome.The early origins of COPD in severe asthma: the one thing that leads to another or the two things that come together?Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.Lipid phenotyping of lung epithelial lining fluid in healthy human volunteersNeutrophil gelatinase-associated lipocalin as a complementary biomarker for the asthma-chronic obstructive pulmonary disease overlap
P2860
Q26745760-A46C6A50-B5E8-4433-BA8F-02154C95BF81Q28070274-ED94B176-9682-4D44-A69E-B61D251B1725Q33592440-F34CAEAD-3D80-467C-9E5D-9DBDF55BED0EQ33613288-1F2E39D6-D7D5-4577-8DCF-6B498FE391B7Q33844617-618E4CDD-43DA-4D94-8499-001528693076Q34217270-0A779538-0636-4229-BC9D-328429466FC7Q34808077-E1600E5C-5B16-40CC-9BAC-1B4EF1987D1AQ35042664-BF25F9C3-B89F-4641-9DAF-DE5683C8A15AQ35921132-4E173798-3D30-4170-AB3C-E267E9D38422Q36036910-327DF70B-F2B1-4979-9A76-E69857033C6CQ36842527-A85F9D1C-6B3F-4C42-953A-11C9CB9C6026Q37252328-35CDB0E8-E7BA-46CF-B55A-9D7D4E120FCDQ37316797-03BBC2CC-3D65-4720-B92B-712754ECC5D6Q37622312-64AC9EA5-C757-437D-AD59-B031146F9472Q37663904-71E9F5C8-A1F8-4E0E-983E-25A0459E2968Q37709578-8CFE15E8-A280-4E1B-9608-9DF4DB4ECA47Q38159723-A7C6721C-DA63-46FB-BE87-D93A41BC25ACQ38245908-FC1700BD-BCEE-4B3F-9AA7-AF72C7EBA41EQ38364870-89B13BC3-9D7F-4DF8-BE4A-8BB5E9B967F3Q38541559-D1EFBFAB-CFD3-48CB-A416-406CABBD00F5Q38544747-4EAF19EA-B425-42A7-8DE3-028DD6D077DCQ38644007-60C38754-28CC-4334-9255-09E5AFDE521CQ38661408-0B44F82B-205A-495A-8C5C-12E3A86C9F12Q38739067-DD1552B9-9C9A-42F6-BAB3-CA54EE69638CQ39243181-122808CF-A03E-4589-A43A-C6DF41367DB7Q40998786-898A3B6A-8C5B-4C95-B46E-801E57B15A20Q42376769-EC6EC263-10CF-4F64-82A5-9D26B02FC294Q47849470-F392ABBD-4027-41FA-A2E2-5D3F126FE918Q49758922-0E0DCC1E-3764-4808-8E56-44EBB6562865Q51724755-CFB2F8CF-D812-4FF3-AC8A-F1EE6C415445Q55049104-6F9DF5BF-E320-478A-8889-F9262553C506Q58731392-2AFB71BF-CB13-4B94-B4C8-C9ADC603F6D7Q58804471-0189205E-38F1-444A-8C4D-37EEC6202C97
P2860
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap.
@en
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap.
@nl
type
label
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap.
@en
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap.
@nl
prefLabel
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap.
@en
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap.
@nl
P2093
P921
P1476
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap.
@en
P2093
Hideo Kobayashi
Hiroshi Iwamoto
Tarja Laitinen
Vuokko Kinnula
Witold Mazur
P304
P356
10.1183/09031936.00024313
P577
2013-06-21T00:00:00Z